Ascension Health Ventures leads $14m D round for Ocular Therapeutix.
Category: Deals
Twitpay scores with CompuCredit
Twitpay provides payment software for social media platforms and also added venture capital firm TomorrowVentures to its investor consortium alongside CompuCredit, which spun off its micro-payments units in the UK and US in mid-2009.
Transpera’s earth moves for Tremor
US-based Tremor Media, which provides video advertising services, is buying peer Transpera, according to news provider TechCrunch.
Inventages tucks into Tanfield
Inventages had invested $6m in Tanfield Food Company in January last year and adds a further $1m this year.
Digitalsmiths buys Gotuit
Digitalsmiths, a video indexing and publishing technology provider, has bought Gotuit Media for an undisclosed sum.
Investors answer To-BBB’s question
Dutch healthcare investor Jonghoud International and Industrial Bank of Taiwan Management’s Boston Life Science fund are new investors in To-BBB’s $5.5m B round, alongside existing investors Aescap Venture and Antea Participaties.
Skype diaspora tune into Rdio
Skype, an online phone operator started by entrepreneurs Niklas Zennstrom and Janus Friis, has invested in Rdio. Skype’s investment came alongside one of its own original venture capital backers, Mangrove Capital Partners, which is a new investor in Rdio, and Zennstrom and Friis’s new investment company Atomico.
NEL and Fujikura back Nistica
Japan-based manufacturers Fujikura and NTT Electronics (NEL) back Nistica’s D round.
Motricity buys Adenyo
Motricity will pay an initial $100m in cash and potentially shares with up to a further $50m in performance fees based on targets for the next 12 months for Adenyo.
Verve breaks down Deconstruct
Verve hires Tom MacIsaac as chief executive ahead of buying Deconstruct Media.
Company sings for Aria C round
Aria Systems has now raised $34m in its three rounds since 2003 after latest funding.
Seesmic shifts for its latest round
Seesmic gains $4m from Saleforce.com and Softbank Group.
BG Medicine cuts float range
BG Medicine plans to list 4.75 million shares for $7 each at its initial public offering (IPO), although investment bank Lazard can sell a further 712,500 shares if demand is strong enough. The previous price range was $13 to $15 per share.
Neuralitic hires boss with B round
BlackBerry Partners Fund, a corporate venturing fund backed by investors including phone maker Research In Motion, reinvested in Neuralitic, alongside venture capital firms BDC Venture Capital, Vertex Venture Capital and Go Capital, while Export Development Canada led the round as a new investor. Neuralitic has now raised $20m in total.